[go: up one dir, main page]

CY1108377T1 - Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων - Google Patents

Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων

Info

Publication number
CY1108377T1
CY1108377T1 CY20081101059T CY081101059T CY1108377T1 CY 1108377 T1 CY1108377 T1 CY 1108377T1 CY 20081101059 T CY20081101059 T CY 20081101059T CY 081101059 T CY081101059 T CY 081101059T CY 1108377 T1 CY1108377 T1 CY 1108377T1
Authority
CY
Cyprus
Prior art keywords
treatment
dimethylamino
compounds
fenylo
propanium
Prior art date
Application number
CY20081101059T
Other languages
English (en)
Inventor
Thomas Christoph
Elmar Friderichs
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1108377T1 publication Critical patent/CY1108377T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά την χρήση ενώσεων 1-φαινυλο-3-διμεθυλαμινο-προπανίου για την παρασκευή ενός φαρμάκου για την θεραπεία της συχνής στραγγουρίας ή της ακράτειας ούρων, καθώς και αντίστοιχα φάρμακα και μέθοδοι για την θεραπεία της συχνής στραγγουρίας ή της ακράτειας ούρων.
CY20081101059T 2000-11-30 2008-09-25 Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων CY1108377T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10059412A DE10059412A1 (de) 2000-11-30 2000-11-30 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
EP01984781A EP1438034B1 (de) 2000-11-30 2001-11-28 Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz

Publications (1)

Publication Number Publication Date
CY1108377T1 true CY1108377T1 (el) 2014-02-12

Family

ID=7665210

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101059T CY1108377T1 (el) 2000-11-30 2008-09-25 Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων

Country Status (28)

Country Link
US (1) US6841575B2 (el)
EP (1) EP1438034B1 (el)
JP (1) JP4284066B2 (el)
KR (1) KR100853364B1 (el)
CN (1) CN100421654C (el)
AT (1) ATE402694T1 (el)
AU (2) AU3321002A (el)
BR (1) BR0115882A (el)
CA (1) CA2430332C (el)
CY (1) CY1108377T1 (el)
CZ (1) CZ20031508A3 (el)
DE (2) DE10059412A1 (el)
DK (1) DK1438034T3 (el)
EC (1) ECSP034635A (el)
ES (1) ES2311030T3 (el)
HU (1) HU228827B1 (el)
IL (2) IL156170A0 (el)
MX (1) MXPA03004712A (el)
NO (1) NO334109B1 (el)
NZ (1) NZ526603A (el)
PL (1) PL205081B1 (el)
PT (1) PT1438034E (el)
RU (1) RU2286768C2 (el)
SI (1) SI1438034T1 (el)
SK (1) SK287420B6 (el)
UA (1) UA74608C2 (el)
WO (1) WO2002043715A2 (el)
ZA (1) ZA200305006B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109763A1 (de) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
US20050176790A1 (en) 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224108A1 (de) * 2002-05-29 2004-01-29 Grünenthal GmbH 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
US7410965B2 (en) 2002-05-29 2008-08-12 Gruenenthal Gmbh Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
DE10224624A1 (de) * 2002-05-30 2003-12-11 Gruenenthal Gmbh Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
DE10225315A1 (de) * 2002-06-06 2003-12-24 Gruenenthal Gmbh Wirkstoffsalze und Ester von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl- pentan-3-ol und 3-(3-Dimethylamino-1-ethyl-1-hydroxy-2-methyl- propyl)-phenol
PT1562567T (pt) 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii
NZ592057A (en) * 2008-09-05 2013-01-25 Acucela Inc Sulfur-linked compounds for treating opthalmic diseases and disorders
EP2617706B1 (en) 2011-07-29 2017-09-06 Anhui New Star Pharmaceutical Development Co., Ltd Novel intermediate used for preparing tapentadol or analogues thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213219B (it) * 1984-09-28 1989-12-14 Consiglio Nazionale Ricerche Derivati amminoalchilnaftalenici ad attivita' farmacologica.
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US5561154A (en) * 1994-07-27 1996-10-01 Institut De Recherches Chimiques Et Bioloques Appliquees Irceba Treatment of acute urinary retention
US6090856A (en) * 1997-04-11 2000-07-18 Nippon Shinyaku Co., Ltd. Remedies for frequent urination and urinary incontinence
DE19933421A1 (de) * 1999-07-16 2001-01-25 Gruenenthal Gmbh 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate

Also Published As

Publication number Publication date
BR0115882A (pt) 2003-12-02
NO20032406L (no) 2003-05-27
WO2002043715A2 (de) 2002-06-06
NO20032406D0 (no) 2003-05-27
US20040034105A1 (en) 2004-02-19
EP1438034B1 (de) 2008-07-30
UA74608C2 (uk) 2006-01-16
HUP0302430A2 (hu) 2003-10-28
PT1438034E (pt) 2008-08-22
SK6632003A3 (en) 2004-08-03
DE10059412A1 (de) 2002-06-13
NZ526603A (en) 2005-10-28
US6841575B2 (en) 2005-01-11
ECSP034635A (es) 2003-07-25
KR20030059294A (ko) 2003-07-07
JP2004538246A (ja) 2004-12-24
SI1438034T1 (sl) 2008-12-31
CA2430332C (en) 2011-03-15
DE50114181D1 (de) 2008-09-11
ES2311030T3 (es) 2009-02-01
RU2286768C2 (ru) 2006-11-10
CA2430332A1 (en) 2002-06-06
PL205081B1 (pl) 2010-03-31
CN1622803A (zh) 2005-06-01
SK287420B6 (sk) 2010-09-07
JP4284066B2 (ja) 2009-06-24
HUP0302430A3 (en) 2009-08-28
WO2002043715A3 (de) 2004-04-15
DK1438034T3 (da) 2008-12-01
AU3321002A (en) 2002-06-11
HK1068274A1 (zh) 2005-04-29
IL156170A (en) 2007-02-11
AU2002233210B2 (en) 2006-05-11
ZA200305006B (en) 2007-11-28
MXPA03004712A (es) 2003-08-19
NO334109B1 (no) 2013-12-09
PL366051A1 (en) 2005-01-24
CZ20031508A3 (cs) 2003-10-15
HU228827B1 (hu) 2013-05-28
IL156170A0 (en) 2003-12-23
EP1438034A2 (de) 2004-07-21
CN100421654C (zh) 2008-10-01
KR100853364B1 (ko) 2008-08-22
ATE402694T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
CY1110019T1 (el) Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες
CY1110322T1 (el) Αναστολεις της her3 δραστικοτητας
DE50208214D1 (de) Saure hochquellfähige hydrogele
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
CY1112753T1 (el) Θεραπευτικη αγωγη καρκινων του ανθρωπινου σωματος με τη χρηση toy ετ743
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
SE0003476D0 (sv) Compounds
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
BRPI0412694A (pt) compostos
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
SE0004827D0 (sv) Therapeutic compounds
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.
ATE308513T1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
CY1105814T1 (el) Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης
EA200300789A1 (ru) Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи